Red List

REPLReplimune Group, Inc.

Healthcare · Biotechnology · small-cap ($733M)
-33.5%
from rolling 252-day high of $16.33 set 2026-09-02 · 44d ago
Current
$10.86
Decline depth
-33.5%
Decline σ
6.2σ
TFC
2/5 bearish

Where it stands

On the Red List.

Down 33.5% from its rolling 252-day high, 44 days after the high.

Snapshot . Price structure, not a judgment about the business.

What changed

Since the previous observation.

Amber List → Red List.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

REPL qualifies for the Red List on decline depth.

Down 33.5% from its rolling 252-day high, 44 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-33.5%
From rolling 252-day high of $16.33, 44d ago. Past the 30% Amber threshold.
Time-frame continuity
2/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
6.2σ
Drop over the last 20 bars in units of daily volatility (3.54%/day). Past the ≥6σ Amber threshold.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-05-15. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. Amber List → Red List
  2. Red List → Amber List
  3. Amber List → Red List
  4. Watch → Amber List
  5. Amber List → Watch
  6. Watch → Amber List
  7. Unmatched; coverage or recovery unconfirmed → Watch
  8. Red List → Unmatched; coverage or recovery unconfirmed
  9. Amber List → Red List
  10. Red List → Amber List
  11. Watch → Red List
  12. Unmatched; coverage or recovery unconfirmed → Watch

Showing the latest 12 of 26 recorded events.

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Technical interpretation and signal details

The structural read

What price action says about REPL.

REPL qualifies for the Red List on decline depth — down -33.5% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause in the classification rules. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: decline sigma also reads 6.2σ over 20 bars.

Earnings on file: 2026-02-03. Earnings dates don't affect tiering.

Questions about REPL

What people ask.

Why is REPL on Broken Stocks?

REPL qualifies for the Red List on decline depth. It is down -33.5% from its rolling 252-day high of $16.33, set on 2026-09-02 — 44d ago.

Is REPL a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. REPL is down -33.5% from its 52-week high of $16.33, set 44d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — the classification does not predict subsequent returns. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is REPL a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is REPL trading inside its 52-week range?

At $10.86, REPL sits 79.7% of the way from its 52-week low ($1.50) to its 52-week high ($13.24). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has REPL been declining?

The current 33.5% decline accrued over 44d, which annualizes to roughly -277.9% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does REPL compare to its sector?

There are 408 other Healthcare tickers on Broken Stocks: 273 Red, 95 Amber, 40 Watch, with 178 showing recovering structural signals. Median sector decline is -37.5% — REPL's decline is shallower than the sector median.

Does REPL's earnings date affect its tier?

No. Tiering uses decline depth and recency, bearish time-frame structure, and decline sigma. The earnings date on file (2026-02-03) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.